A virtual Experts Knowledge Share on the topic ‘Incorporating PARP inhibitors into prostate cancer clinical practice’ chaired by Prof. Fred Saad (Canada) and co-chaired by Assoc. Prof. Tanya Dorff (USA), Prof. Gerhardt Attard (UK) and Prof. Neeraj Agarwal.
Learn about and discuss how to:
1) Recognise the efficacy and safety profiles of PARP inhibitors for patients with prostate cancer, including an overview of the data in other tumour types
2) Implement testing strategies to predict if a patient with prostate cancer is likely to respond to a PARP inhibitor or some other treatment
3) Understand the data from combination studies with PARP inhibitors, their appropriate implementation in treatment strategies, and their impact on clinical practice
You will also have the opportunity to contribute to the discussion on this important topic in genitourinary oncology. If you would like to ask the faculty a specific question, please include this on your Pre-Event Survey.